Crosspoint Capital Strategies’s Medifast MED Stock Holding History

Crosspoint Capital Strategies’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,798	Closed	-$2.39M	–	40
2018 Q3	$2.39M	Sell	10,798 -319	-3%	-$64.7K	3.92%	4
2018 Q2	$1.78M	Buy	+11,117	New	+$1.42M	3.41%	4
2018 Q1	–	Sell	-162	Closed	-$113K	–	55
2017 Q4	$113K	Buy	+162	New	+$10.7K	0.01%	81
2016 Q1	–	Sell	-500	Closed	-$17K	–	535
2015 Q4	$17K	Buy	+500	New	+$14.9K	﹤0.01%	622
2015 Q1	–	Sell	-835	Closed	-$28K	–	658
2014 Q4	$28K	Hold	835	–	–	0.01%	404
2014 Q3	$27K	Sell	835 -70	-8%	-$2.15K	0.02%	275
2014 Q2	$26K	Hold	905	–	–	0.01%	306
2014 Q1	$26K	Hold	905	–	–	0.01%	334
2013 Q4	$24K	Buy	+905	New	+$23.2K	0.01%	332

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Crosspoint Capital Strategies's MED Position: Q4 2018 in Review

Crosspoint Capital Strategies sold out of Medifast (MED) in Q4 2018, closing a stake of 10,798 shares — an estimated $2.39M sold.

Crosspoint Capital Strategies first reported a position in MED in Q4 2013 and held it in 9 quarters. The position peaked at $2.39M in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Crosspoint Capital Strategies reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Crosspoint Capital Strategies sold 10,798 Medifast shares in Q4 2018, an estimated $2.39M.
Crosspoint Capital Strategies first reported a position in Medifast in Q4 2013 and held it in 9 quarters.
Crosspoint Capital Strategies's Medifast position peaked at $2.39M in Q3 2018.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2018, filed 13 Feb 2019.